Boundless Bio, Inc. BOLD
2.44 USD +0.06 (+2.52%)
Nov 4, 2026, 2:50 PM EST
2.40 Day range 2.45
0.961 52-week range 3.16
- YTD
- +103.33%
- 1 year
- +87.69%
Financial health
Altman Z-Score
-3.21 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -0.5×
FY 2016 5y median -6.4× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.3×
FY 2016 5y median -2.5× FY 2025
P/FCF -0.6×
FY 2016 5y median -6.7× FY 2025
EV/EBITDA -1.0×
FY 2016 5y median -6.1× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -175.9%
FY 2016 5y median -15.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -59.0%
FY 2016 5y median 38.9% FY 2025
ROIC -43.0%
FY 2016 5y median -43.0% FY 2025
ROA -37.1%
FY 2016 5y median -37.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 13.3%
FY 2016 FY 2025
EPS (diluted) 32.5%
FY 2016 FY 2025
Free Cash Flow 25.5%
FY 2016 FY 2025
Financial Health
Current Ratio 8.7×
FY 2016 5y median 13.3× FY 2025
Quick Ratio 8.7×
FY 2016 5y median 13.3× FY 2025
Debt / Equity 0.5×
FY 2016 5y median -0.0× FY 2025
Net Debt / EBITDA -0.5×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31